Clinical Trial Update: A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nonsteroidal aromatase inhibitors in combination with abemaciclib for postmenopausal women with breast cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Nonsteroidal aromatase inhibitors

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2018-03-23